TraveraRTGx
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TraveraRTGx, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)